The release of tumor necrosis factor–α is associated with ischemic tolerance in human stroke
- 26 November 2003
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 54 (6) , 811-819
- https://doi.org/10.1002/ana.10765
Abstract
Tumor necrosis factor (TNF)–α overexpression has been related to experimental ischemic tolerance when transient ischemia precedes cerebral infarction. We investigated TNF‐α and interleukin (IL)–6 plasma concentrations in 283 patients with an acute stroke within 24 hours after symptom onset. An ipsilateral transient ischemic attack (TIA) within 72 hours before stroke was recorded in 38 patients. The infarct volume measured on computed tomography on days 4 to 7 and the frequency of poor outcome (Barthel Index score < 85) at 3 months were significantly lower in patients with prior TIA. Plasma concentrations of TNF‐α were higher (42.5 ± 9.9 vs 13.1 ± 6.4pg/ml, p < 0.0001) and IL‐6 levels were lower (10.1 ± 6.2 vs 28.3 ± 17.3pg/ml, p < 0.0001) in patients with prior TIA. A new variable termed TNF‐α/IL‐6 index was considered positive when TNF‐α was greater than 30pg/ml and IL‐6 was less than 30pg/ml. Positive TNF‐α/IL‐6 index was found in 92% of patients with prior TIA and in 1% of those without. TNF‐α/IL‐6 index (p = 0.0003) and TIA (p = 0.0001) were associated with good outcome in logistic regression analysis after adjusting for potential confounding factors. Ischemic tolerance in acute stroke is associated with increased plasma levels of TNF‐α in the presence of reduced concentrations of IL‐6. Ann Neurol 2003;54:811–819Keywords
This publication has 52 references indexed in Scilit:
- Ischemia and Ischemic Tolerance Induction Differentially Regulate Protein Expression of GluR1, GluR2, and AMPA Receptor Binding Protein in the Gerbil HippocampusStroke, 2002
- Hypoxia Inhibition of Apoptosis Induced by Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)Biochemical and Biophysical Research Communications, 2002
- Improving the Reliability of Stroke Subgroup Classification Using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) CriteriaStroke, 2001
- Proinflammatory Cytokines and Early Neurological Worsening in Ischemic StrokeStroke, 2000
- Lack of Interleukin-6 Expression Is Not Protective Against Focal Central Nervous System IschemiaStroke, 2000
- Detection of Tumor Necrosis Factor-α mRNA Induction in Ischemic Brain Tolerance by Means of Real-Time Polymerase Chain ReactionJournal of Cerebral Blood Flow & Metabolism, 2000
- Attenuated Stroke Severity After Prodromal TIAStroke, 1999
- Ischemic Preconditioning and Brain Tolerance: Temporal Histological and Functional Outcomes, Protein Synthesis Requirement, and Interleukin-1 Receptor Antagonist and Early Gene ExpressionStroke, 1998
- Expression of bcl-2 From a Defective Herpes Simplex Virus–1 Vector Limits Neuronal Death in Focal Cerebral IschemiaStroke, 1995
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993